← Browse by Condition
Medical Condition
primary myelofibrosis
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT07228624 Phase 2
Recruiting
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
Enrollment
50 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT04370301 Phase 2
Recruiting
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
Enrollment
20 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center